Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Primary objective:
To compare long-term glycemic control and preservation of beta cell function when basal
insulin or sulfonylurea is added on metformin in the early Type 2 Diabetes Mellitus patients
Secondary objective:
To assess the change of insulin resistance, microvascular complication incidence, patient
satisfaction with treatment